Institut de Neuropsiquiatria i Addicions, Hospital del Mar-IMIM, Parc de Salut Mar, Passeig Marítim 25–29, Barcelona, Spain.
Subst Use Misuse. 2012 Jun-Jul;47(8-9):1005-14. doi: 10.3109/10826084.2012.663296.
Psychiatric co-morbidity among substance users refers to the simultaneous presence of at least another psychiatric disorder in a person diagnosed with a substance use disorder. Co-morbid patients represent a substantial number of people in treatment and present greater disorder severity from both the clinical and social perspectives than those people diagnosed with only one type of disorder. We present an overview of the current state of the art concerning the choice of site of treatment, the kind of intervention, the length of such treatment, and future goals, aiming to establish a more effective intervention, and finally so as to further improve clinical outcomes.
物质使用者的精神共病是指在诊断患有物质使用障碍的个体中同时存在至少另一种精神障碍。共病患者在治疗中占相当大的比例，从临床和社会角度来看，他们的疾病严重程度比仅诊断出一种疾病的患者更严重。我们概述了目前关于治疗地点选择、干预类型、治疗时间长短和未来目标的选择，旨在建立更有效的干预措施，最终改善临床结果。
